Glen E. Tullman | |
|---|---|
 | |
| Nationality | American |
| Occupation | CEO | Managing Partner |
| Organization | Transcarent | 7wire Ventures |
Glen E. Tullman is an American entrepreneur and investor who has built, run, and scaled businesses across a range of industries. He is the founder and executive chairman of Livongo Health, a consumer digital health company and previously served as the CEO of Allscripts.
Tullman was born circa 1960, near Chicago, Illinois and is the youngest of six children. [1] He his family moved to the New York area when he was in fourth grade. Tullman received his undergraduate degree in 1981 in economics and psychology from Bucknell University. [1] He also spent a year in Oxford, England studying social anthropology on a Rotary International fellowship through the Office of Management and Budget. [1]
One of Tullman's first jobs after graduation was at Certified Collateral Corporation in Illinois where he worked for approximately 10 years. He also served as the CEO of Enterprise Systems, leading it through its initial public offering and eventual sale to McKesson Corporation. [1] [2]
In 1997, Tullman became the CEO of Allscripts, a large electronic health record and health information technology company. He was the CEO of the company for 15 years prior to leaving in 2012. [3] Tullman was CEO of the company when it went public. [1] After leaving Allscripts, Tullman co-founded and became the managing partner at 7Wire Ventures, a $100 million venture capital firm that is focused on investing in healthcare firms. [4]
Tullman has invested in and/or co-founded more than 20 businesses throughout his career, [3] including SoCore Energy, a commercial solar panel installation company that was later purchased by Edison International. [5] He also founded a classroom technology company called Modern Teacher. [6]
In 2014, Tullman founded Livongo, a digital health company that provides connected devices and health platforms for people with chronic conditions like diabetes, and other medical conditions; [7] Tullman's son is diabetic and he saw a market need for such patients. [8] The company went public in 2019. [9] Livongo was sold to Teladoc for $18.5B in 2020. [10] He resigned from the Teladoc board in 2020 to avoid any conflict of interest with his new company, Transcarent. [11]
Tullman holds various executive positions outside of Transcarent. He serves on the board and is an investor in WiserTogether, a crowd sourced healthcare information company. He is Director Emeritus of JDRF, [12] a board member of the American Diabetes Association, as well as a contributor to Forbes, through 2016. [13] He also serves as executive chairman of ArgoTea, the co-founder and Vice Chairman of Cooler Screens, and owns Ignite Glass Studios, a venue featuring glassblowing classes, [14] exhibits, and event space in Chicago. [15]
Since 2021, Tullman has served as Chief Executive Officer and Founder of Transcarent, which sells an integrated healthcare benefits system bringing a new and different health and care experience to large and mid-sized self-insured employers, their employees and their families in the United States.
In 2021 Tullman was named a Forbes Healthcare Top 10 Leader of the Decade. [16]
Daniel Gilbert is an American billionaire, businessman, and philanthropist. He is the co-founder and majority owner of Rocket Mortgage, founder of Rock Ventures, and owner of the National Basketball Association's Cleveland Cavaliers. Gilbert owns several sports franchises, including the American Hockey League's Cleveland Monsters, and the NBA G League's Cleveland Charge. He operates the Rocket Mortgage FieldHouse in Cleveland, Ohio, home to the Cavaliers and Monsters. As of January 2023, Forbes estimated his net worth at US$18.3 billion.
Kevin P. Ryan is an American investor and entrepreneur who has founded several New York–based businesses, including Gilt Groupe, Business Insider and MongoDB. Ryan helped grow DoubleClick from 1996 to 2005, first as president and later as CEO. Ryan continues to found and invest in companies through AlleyCorp, a venture capital firm he founded with Dwight Merriman in 2008. He holds a B.A. from Yale University and an M.B.A. from INSEAD.
John A. Canning Jr. is a private equity investor and sports executive. He is the founder and chairman of Madison Dearborn Partners, the large Chicago-based private equity firm.
HealthCentral is an American privately owned digital health media company. The company owns and operates consumer health brands HealthCentral.com, TheBody.com, and PatientPower.info, as well as brands for medical professionals including MedCentral.com, TheBodyPro.com, and OncologyNewsCentral.com.
Mark Tebbe is an adjunct professor of Entrepreneurship at the University of Chicago's Booth School of Business where he helped develop and co-teaches the Entrepreneurial Discovery class having served in this role since 2011. In addition to his appointment as adjunct professor, Mark is an Entrepreneur-in-Residence in Booth's Polsky Center for Entrepreneurship and Innovation where he mentors students and advises faculty in developing technological business techniques. He is an active investor and mentor to various companies in the startup ecosystem as part of Hyde Park Angels.
David B. Snow Jr. is an American business executive currently serving as the chairman and chief executive officer (CEO) of Cedar Gate Technologies, a healthcare predictive and prescriptive analytics company. He previously served as the CEO of Medco Health Solutions, the largest pharmacy benefits manager in the United States by revenue. He founded Americhoice, a drug development company he sold to UnitedHealth Group for $570 million.
Jeffrey Weiner is an American businessman. He was the chief executive officer (CEO) of LinkedIn, a business-related social networking website. He started with LinkedIn on December 15, 2008, as Interim President. Weiner played an instrumental role in LinkedIn's acquisition by Microsoft for $26 billion in June 2016. Currently, he is the Executive chairman of Linkedin as of 2022. He is also the founding Partner of Next play venture capital.
Bradley A. Keywell is an American billionaire entrepreneur. He is the founder and executive chairman of Uptake Technologies, an industrial AI software provider. He is an early investor of Tempus Labs, co-founder of Groupon, Echo Global Logistics, Mediaocean, DRIVIN, and Lightbank. He founded WNDR Museum and Chicago Ideas.
Howard A. Tullman is an American serial entrepreneur, venture capitalist, educator, writer, lecturer, and art collector. He is the former executive director of the Ed Kaplan Family Institute for Innovation and Tech Entrepreneurship at Illinois Tech in Chicago and the first University Professor appointed at IIT. He is the former CEO of 1871, the current General Managing Partner of G2T3V, LLC, and the current General Managing Partner of Chicago High Tech Investment Partners LLC, both early stage venture capital funds based in Chicago.
Karin M. Hehenberger is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology. She has written numerous articles on biotechnology that have been published in peer review journals and worked as an executive for different biotechnology companies and investment firms. She is a faculty member in the department of Molecular Medicine at the Karolinska Institute where she also obtained her M.D. and a Ph.D. in molecular medicine. She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine and industry challenges as well as provided commentary for Fox News, Good Morning America Health, New York One, the USA Today and Forbes.
Michael W. Ferro Jr. is an American businessman and tech entrepreneur, founder of Click Commerce and Higi, as well as several other companies including Merrick Ventures, a Chicago-based private equity firm. From February 2016 to March 2018, he was the non-executive chairman of Tribune Publishing, one of the largest newspaper publishers in the United States.
Jeff Aronin is an American investor, entrepreneur, and biotechnology executive. He is founder, chairman and CEO of Paragon Biosciences, LLC, a global life science company that creates, builds, and funds innovative biology-based companies.
Joseph Robert Swedish is an American healthcare executive and leader. He is a former senior adviser to the board of directors at Anthem, Inc., a Fortune 29 company, and was the CEO of Anthem, Inc. from 2013 to 2017. For 12 years in a row Swedish was named Modern Healthcare’s one of the 100 Most Influential People in Healthcare.
Pete Flint OBE is a British internet entrepreneur and investor based in San Francisco. He is the founder and former chairman and CEO of Trulia. Formerly, he was part of the founding team at lastminute.com. He is currently a managing partner at NFX, the early stage venture capital fund focused on network effect businesses.
Sapphire Ventures is a venture capital firm with offices in Menlo Park, San Francisco, Austin, and London. The firm is considered one of the world's premier venture capital firms.
Teladoc Health, Inc. is a multinational telemedicine and virtual healthcare company headquartered in the United States. Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services. In particular, Teladoc Health uses telephone and videoconferencing software as well as mobile apps to provide on-demand remote medical care.
Flexport Inc. is an American multinational corporation that focuses on supply chain management and logistics, including order management, delivery, trade financing, insurance, freight forwarding, and customs brokerage. The company is headquartered in San Francisco, California, has thousands of employees and annual revenues of more than $3.3 billion.
Cyrus Massoumi is the founder of telehealth service Dr. B and the founder of the investment fund humbition. He is also the founder of Zocdoc and was the company CEO for eight years.
Outcome Health is a Chicago-based healthcare technology company founded by Rishi Shah. Its registered name is ContextMedia Health LLC. It is majority owned by Littlejohn & Co., a private equity firm. Its founders were indicted and convicted by a federal grand jury on multiple charges of fraud and also sued by the SEC, with veteran tech investor Howard A. Tullman describing Outcome as "our version of Theranos."
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
